Asian stocks rise after Wall Street hits new high

By: |
January 4, 2021 10:26 AM

Optimism about vaccines has countered concern about rising infection numbers in the United States and some other countries and conflict over economic aid in Washington, said Stephen Innes of Axi in a report.

asian marketsVaccine development by U.S., European and Chinese producers has helped investor optimism that a return to normal might be closer after the global economy's worst decline since the 1930s. (Photo source: AP)

Asian stock markets rose Monday on 2021’s first trading day, boosted by optimism about the rollout of coronavirus vaccines after Wall Street ended the year on a new high. Market benchmarks in Shanghai, Hong Kong, Seoul and Sydney advanced. Tokyo declined.

Optimism about vaccines has countered concern about rising infection numbers in the United States and some other countries and conflict over economic aid in Washington, said Stephen Innes of Axi in a report.

Traders are perhaps a bit over-eager but believe vaccines will  provide the ultimate economic kick-start, offering a massive booster shot to corporate profits, said Innes.

The Shanghai Composite Index gained 0.3per cent to 3,481.98 and the Hang Seng in Hong Kong gained 0.3per cent to 27,308.63. The Nikkei 225 in Tokyo was off 0.4per cent at 27,344.87 after Prime Minister Yoshihide Suga announced the government is considering declaring a state of emergency for Tokyo and three surrounding prefectures due to surging virus caseloads. Suga asked restaurants and bars to close by 8 p.m. and said it would be difficult to restart a controversial travel promotion program that was suspended last month. He also said the government would expedite approval of coronavirus vaccines and begin providing injections in February.

The Kospi in Seoul rose 2per cent to 2,930.38 and Sydney’s S&P-ASX 200 added 0.2per cent to 6,661.10. Singapore and Jakarta also advanced. On Wall Street, the benchmark S&P 500 index rose 0.6per cent to a high of 3,756.07 on Thursday, its final trading day of 2020. It ended the year up 16.3per cent, or a total return of about 18.4per cent with dividends.

The Dow Jones Industrial Average rose 0.7per cent to a record 30,606.48. The Nasdaq composite added 0.1per cent to 12,888.28. Vaccine development by U.S., European and Chinese producers has helped investor optimism that a return to normal might be closer after the global economy’s worst decline since the 1930s.

The United States and Britain have approved Pfizer Inc.’s vaccine and Britain approved a second vaccine from AstraZeneca and Oxford University. The Chinese government has approved its first domestically developed vaccine. Others are being tested.

Governments might not throw as much stimulus at their economies as they did last year, but policy is still at a very loose setting, which supports stock prices and lending, said Kerry Craig of JP Morgan Asset Management in a report. Investors should look through the bumpier start to the new economic cycle and focus on the improved earnings outlook, Craig said.

In energy markets, benchmark U.S. crude gained 56 cents to USD49.08 per barrel in electronic trading on the New York Mercantile Exchange. The contract rose 12 cents on Thursday to USD48.52. Brent crude, used to price international oils, added 67 cents to USD52.47 per barrel in London. It rose 17 cents the previous session to USD51.80.

The dollar declined to 102.99 yen from Thursday’s 103.27. The euro rose to USD1.2258 from USD1.2211.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1SBI executes inter-bank money market transactions linked to SOFR
2Indigo Paints IPO subscribed 1.90 times on first day
3BharatPe raises Rs 50 cr debt from Trifecta Capital